DARPP-32 and t-DARPP isoform in non-small cell lung cancer (NSCLC): could they drive patients' clinical management and be a therapeutic target?

Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S326-S328. doi: 10.21037/tlcr.2018.12.06.

Authors

Giuseppe Lamberti^{1

2}, Chiara Peterle^{1

2}, Francesco Gelsomino¹

Affiliations

¹ Medical Oncology Unit, Policlinico S.Orsola-Malpighi, Bologna, Italy.
² Department of Specialized, Experimental and Diagnostic Medicine, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.

No abstract available

Publication types

Editorial
Comment